T. Birsan et al., FUNCTIONAL RESULTS AND LONG-TERM OUTCOME AFTER BILATERAL LUNG TRANSPLANTATION FOR PULMONARY-HYPERTENSION, Wiener Klinische Wochenschrift, 110(2), 1998, pp. 45-52
Pulmonary hypertension (PH) signifies elevated blood pressure in the p
ulmonary circulation either due to clearly defined causes (cardiac, pu
lmonary-parenchymatous, systemic) or of idiopathic origin (primary PH,
PPH). While conservative treatment is beneficial only for a small num
ber of patients, lung transplantation represents a curative measure. T
he optimal form of transplantation [i. e. single lung (SLTX), bilatera
l lung (BLTX) or combined heart-lung transplantation (HLTX)] is still
under discussion. This study is a retrospective analysis of 16 patient
s with different forms of PH who underwent BLTX from 1992 to 1996 in V
ienna. Four patients had Eisenmenger's disease due to atrial septum de
fect, 3 had chronic thromboembolic PH and 9 had PPH. BLTX with cardiop
ulmonary bypass was the standard procedure in all patients. Acute retr
ansplantation had to be performed in 3 patients. Mean pulmonary arteri
al pressure was reduced from 63 +/- 11 mmHg preoperatively to 23 +/- 5
mmHg on the second day postoperatively (p < 0.0001), while the cardia
c index concomitantly improved from 2.1 +/- 0.5 to 3.9 +/- 1.2 l/min/m
(2) (p < 0.05). Echocardiography proved normalisation of right ventric
ular wall thickness and end diastolic diameter within 12 months, while
tricuspid insufficiency, present in all patients before transplantati
on, resolved completely. Perioperatively 4 patients (25%) died due to
septic complications (n = 3) or therapy refractory rejection (n = 1).
Follow-up of the remaining patients ranged from 6 to 51 months (mean 3
3 +/- 17). One patient died at 8 months due to fungal sepsis. Eleven p
atients (68%) are currently alive. Only 2 of them show functional sign
s of chronic allograft rejection (bronchiolitis obliterans syndrome).
All patients are at present in NYHA functional class I or II. In concl
usion, BLTX results in complete recovery of right ventricular function
and morphology and offers good functional long-term results. Because
SLTX correlates with a high incidence of reperfusion edema, and HLTX i
s seriously limited by the scarcity of donor organs, BLTX should be th
e method of choice for treating end stage PH.